News
Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...
1d
MedPage Today on MSNMost Babies Protected Against RSV During First Season Immunization Was AvailableOverall, 72% of 36,949 infants were immunized in the 2023-2024 RSV season with either the bivalent RSV prefusion F protein ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
The anticipated rollout of updated Covid vaccines this fall might ... If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, requiring fresh trials, it’s extremely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results